Success Metrics

Clinical Success Rate
94.4%

Based on 85 completed trials

Completion Rate
94%(85/90)
Active Trials
8(7%)
Results Posted
27%(23 trials)
Terminated
5(4%)

Phase Distribution

Ph early_phase_1
1
1%
Ph phase_1
68
59%
Ph phase_2
18
16%
Ph not_applicable
4
3%
Ph phase_3
12
10%
Ph phase_4
9
8%

Phase Distribution

69

Early Stage

18

Mid Stage

21

Late Stage

Phase Distribution112 total trials
Early Phase 1First-in-human
1(0.9%)
Phase 1Safety & dosage
68(60.7%)
Phase 2Efficacy & side effects
18(16.1%)
Phase 3Large-scale testing
12(10.7%)
Phase 4Post-market surveillance
9(8.0%)
N/ANon-phased studies
4(3.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

93.4%

85 of 91 finished

Non-Completion Rate

6.6%

6 ended early

Currently Active

8

trials recruiting

Total Trials

115

all time

Status Distribution
Active(12)
Completed(85)
Terminated(6)
Other(12)

Detailed Status

Completed85
unknown10
Recruiting7
Terminated5
Not yet recruiting4
Suspended2

Development Timeline

Analytics

Development Status

Total Trials
115
Active
8
Success Rate
94.4%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (0.9%)
Phase 168 (60.7%)
Phase 218 (16.1%)
Phase 312 (10.7%)
Phase 49 (8.0%)
N/A4 (3.6%)

Trials by Status

unknown109%
withdrawn11%
terminated54%
active_not_recruiting11%
suspended22%
recruiting76%
not_yet_recruiting43%
completed8574%

Recent Activity

Clinical Trials (115)

Showing 20 of 115 trialsScroll for more
NCT07656012Phase 2

Re-evaluating the Duration in Children of TB Treatment

Not Yet Recruiting
NCT05047055

Four Months Moxifloxacin Containing Daily Regimen Study Among New Pulmonary Tuberculosis Patients

Completed
NCT07620041Phase 1

Phase I Study of QLC5508 in Advanced Solid Tumors: C-QTc, Pharmacokinetics (PK) Comparisons and Drug-drug Interaction

Recruiting
NCT06192160Phase 2

Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis

Recruiting
NCT06191692Phase 3

1HP Versus 3HR in the Treatment of Tuberculosis Infection in Vietnam

Withdrawn
NCT05994742Phase 3

An Adaptive Multi-arm Trial to Improve Clinical Outcomes Among Children Recovering From Complicated SAM

Completed
NCT04694586Phase 2

Drug Exposure and Safety of a Shorter Tuberculosis Treatment Based on High-Dose Rifampicin and Pyrazinamide

Suspended
NCT04930744Phase 2

Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)

Completed
NCT05069688Phase 1

Dolutegravir Pharmacokinetics Among HIV/TB Coinfected Children Receiving Standard and High-dose Rifampicin

Recruiting
NCT04311502Phase 2

Clofazimine- and Rifapentine-Containing Treatment Shortening Regimens in Drug-Susceptible Tuberculosis: The CLO-FAST Study

Terminated
NCT05383742Phase 2

Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis

Recruiting
NCT04630145Phase 2

A Study of Bedaquiline Administered as Part of a Treatment Regimen With Clarithromycin and Ethambutol in Adult Patients With Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)

Completed
NCT03082183Phase 1

A Study in Healthy Men to Test Whether Rifampicin Influences the Amount of BI 425809 in the Blood

Completed
NCT02701608Phase 3

Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Staphylococcus

Completed
NCT05372367Phase 1

A Study in People With Advanced Cancer to Test Whether the Amount of BI 907828 in the Blood is Influenced by Taking an OATP Inhibitor or a CYP3 Inhibitor

Completed
NCT00042289

Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy

Completed
NCT03236987Phase 3

CLArithromycin Versus AZIthromycin in the Treatment of Mycobacterium Avium Complex (MAC) Lung Infections

Recruiting
NCT05807399Phase 2

PanACEA - STEP2C -01

Recruiting
NCT07196449Phase 1

Drug-Drug Interaction of Rifampicin and Cyclosporine on Methotrexate Pharmacokinetics in Healthy Subjects

Active Not Recruiting
NCT06064539Phase 1

Study of Drug-drug Interaction of the Effects of Gemfibrozil and Rifampicin on SAR442168 in Healthy Adult Subjects

Completed

Drug Details

Intervention Type
DRUG
Total Trials
115